Zoledronic Acid

In the US, Zoledronic Acid (zoledronic acid systemic) is a member of the drug class bisphosphonates and is used to treat Hypercalcemia of Malignancy, Osteolytic Bone Lesions of Multiple Myeloma, Osteolytic Bone Metastases of Solid Tumors, Osteoporosis, Paget's Disease and Prevention of Osteoporosis.

US matches:

• Zoledronic Acid


• Zoledronic acid Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M05BA,M05BA08

CAS registry number (Chemical Abstracts Service)

0118072-93-8

Chemical Formula

C5-H10-N2-O7-P2

Molecular Weight

272

Therapeutic Category

Calcium regulator

Chemical Names

(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid (WHO)

Phosphonic acid, [1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-

Foreign Names

• Acidum zoledronicum (Latin)
• Zoledronsaeure (German)
• Acide zolédronique (French)
• Acido zoledronico (Spanish)

Generic Names

• Acide zolédronique (OS: DCF)
• CPG 42446 (IS: Ciba-Geigy)
• ZOL 446 (IS)
• Zoledronic Acid (OS: USAN, BAN, USAN)
• CGP 42446 (IS: Ciba-Geigy)

Brand Names

• Acido Zoledronico
  Servycal, Argentina; Servycal, Peru



• Aclasta
  Dipa, Indonesia; Novartis, Canada; Novartis, Denmark; Novartis, United Kingdom; Novartis, Indonesia; Novartis, New Zealand; Novartis, Russian Federation; Novartis, Slovenia; Novartis, Venezuela; Novartis Consumer Health, Peru



• Reclast
  Novartis, United States



• Zoldria
  Pharmaceutical, Venezuela



• Zomera
  Novartis, Israel



• Zometa
  Novartis, Chile; Novartis, China; Novartis, Denmark; Novartis, Indonesia; Novartis, India; Novartis, Sri Lanka; Novartis, Philippines; Novartis, Poland; Novartis, Singapore; Novartis, Thailand; Novartis, Tunisia; Novartis, Taiwan; Novartis, United States



• Zuorui
  Sino-Swed, China



• Aclasta
  Novartis, Argentina; Novartis, Australia; Novartis, Belgium; Novartis, Bulgaria; Novartis, Bahrain; Novartis, Switzerland; Novartis, Czech Republic; Novartis, Germany; Novartis, Ecuador; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Ireland; Novartis, Iceland; Novartis, Italy; Novartis, Luxembourg; Novartis, Netherlands; Novartis, Norway; Novartis, Portugal; Novartis, Romania; Novartis, Sweden; Novartis, Slovakia; Novartis, South Africa; Novartis Europharm, Austria



• Zoldria
  Biotoscana, Colombia



• Zolenat
  Mustafa Nevzat, Turkey



• Zometa
  Novartis, Australia; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, Colombia; Novartis, Czech Republic; Novartis, Germany; Novartis, Ecuador; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Georgia; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Ireland; Novartis, Iceland; Novartis, Japan; Novartis, Luxembourg; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Panama; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, Turkey; Novartis, Venezuela; Novartis, Vietnam; Novartis, South Africa; Novartis Consumer Health, Italy; Novartis Europharm, Austria

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.